TY - JOUR
T1 - Region-based analysis of rare genomic variants in whole-genome sequencing datasets reveal two novel Alzheimer’s disease-associated genes
T2 - DTNB and DLG2
AU - Alzheimer's Disease Neuroimaging Initiative (ADNI)
AU - Prokopenko, Dmitry
AU - Lee, Sanghun
AU - Hecker, Julian
AU - Mullin, Kristina
AU - Morgan, Sarah
AU - Katsumata, Yuriko
AU - Weiner, Michael W.
AU - Fardo, David W.
AU - Laird, Nan
AU - Bertram, Lars
AU - Hide, Winston
AU - Lange, Christoph
AU - Tanzi, Rudolph E.
N1 - Funding Information:
This work was supported by Cure Alzheimer’s Fund, JPB Foundation and NIH R56AG057191 (DWF and YK). The computations in this paper were run in part on the FASRC Cannon cluster supported by the FAS Division of Science Research Computing Group at Harvard University with support from John Morrissey and in part on computers provided by Dell HPC Research Computing Solutions with support by Glen Otero. The funding body has no role in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript. Please refer to the Supplementary Note for full acknowledgements.
Publisher Copyright:
© 2022, The Author(s).
PY - 2022/4
Y1 - 2022/4
N2 - Alzheimer’s disease (AD) is a genetically complex disease for which nearly 40 loci have now been identified via genome-wide association studies (GWAS). We attempted to identify groups of rare variants (alternate allele frequency <0.01) associated with AD in a region-based, whole-genome sequencing (WGS) association study (rvGWAS) of two independent AD family datasets (NIMH/NIA; 2247 individuals; 605 families). Employing a sliding window approach across the genome, we identified several regions that achieved association p values <10−6, using the burden test or the SKAT statistic. The genomic region around the dystobrevin beta (DTNB) gene was identified with the burden and SKAT test and replicated in case/control samples from the ADSP study reaching genome-wide significance after meta-analysis (pmeta = 4.74 × 10−8). SKAT analysis also revealed region-based association around the Discs large homolog 2 (DLG2) gene and replicated in case/control samples from the ADSP study (pmeta = 1 × 10−6). In conclusion, in a region-based rvGWAS of AD we identified two novel AD genes, DLG2 and DTNB, based on association with rare variants.
AB - Alzheimer’s disease (AD) is a genetically complex disease for which nearly 40 loci have now been identified via genome-wide association studies (GWAS). We attempted to identify groups of rare variants (alternate allele frequency <0.01) associated with AD in a region-based, whole-genome sequencing (WGS) association study (rvGWAS) of two independent AD family datasets (NIMH/NIA; 2247 individuals; 605 families). Employing a sliding window approach across the genome, we identified several regions that achieved association p values <10−6, using the burden test or the SKAT statistic. The genomic region around the dystobrevin beta (DTNB) gene was identified with the burden and SKAT test and replicated in case/control samples from the ADSP study reaching genome-wide significance after meta-analysis (pmeta = 4.74 × 10−8). SKAT analysis also revealed region-based association around the Discs large homolog 2 (DLG2) gene and replicated in case/control samples from the ADSP study (pmeta = 1 × 10−6). In conclusion, in a region-based rvGWAS of AD we identified two novel AD genes, DLG2 and DTNB, based on association with rare variants.
UR - http://www.scopus.com/inward/record.url?scp=85127821228&partnerID=8YFLogxK
U2 - 10.1038/s41380-022-01475-0
DO - 10.1038/s41380-022-01475-0
M3 - Journal articles
C2 - 35246634
AN - SCOPUS:85127821228
SN - 1359-4184
VL - 27
SP - 1963
EP - 1969
JO - Molecular Psychiatry
JF - Molecular Psychiatry
IS - 4
ER -
